Lenox Hill Hospital has signed a two-year research alliance with Philips Medical Systems to collaborate on the development of advanced cardiovascular interventional technology. The collaboration will involve Philips' Allura Xper FD10 cardiac
Lenox Hill Hospital has signed a two-year research alliance with Philips Medical Systems to collaborate on the development of advanced cardiovascular interventional technology. The collaboration will involve Philips' Allura Xper FD10 cardiac catheterization lab and StentBoost, a stent imaging interventional tool. Much of the work will be done in the Lenox Hill Heart and Vascular Institute of New York City. The new collaboration, the outgrowth of a 15-year partnership between Lenox and Philips, will focus on a new image processing algorithm and how it can be used with the Allura Xper FD10 cath lab. The goal is to provide enhanced images of the heart that show lesions in greater detail. Philips' StentBoost will also be evaluated to assess its utility in stent placement.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.